Hepatocellular carcinoma (HCC) is usually diagnosed in an advanced stage and has
become the second deadliest type of cancer worldwide. The systemic treatment of advanced …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with a high
mortality rate. It is regarded as a significant public health issue because of its complicated …

Systemic combination therapy of immune checkpoint inhibitors and vascular endothelial
growth factors have provided the basis for improved outcomes in select patients with …

Simple Summary Transplant oncology is an evolving treatment ideal for patients suffering
from various cancers with poor prognoses. The concept essentially is the complete removal …

Simple Summary Cholangiocarcinoma is a relatively rare but deadly disease with
traditionally limited treatment options. The disease can be categorized by anatomic location …

Liver transplantation (LT) is a highly curative therapy for patients with hepatocellular
carcinoma (HCC). However, due to the shortage of donor livers and rapid progression of …

Simple Summary Cholangiocarcinoma constitutes around 3% of gastrointestinal cancers,
and mortality from this cancer has been rising in the recent decades. Many cases of …

Background: The management of cholangiocarcinoma is continually reviewed on a current
evidence basis to develop practice guidelines and consensus statements. However, the …

Simple Summary Immune checkpoint inhibitors (ICIs) are being increasingly used after
primary treatment of early-stage tumors to treat any residual disease and prevent …

The emerging field of immuno-oncology has brought exciting developments in the treatment
of hepatocellular carcinoma (HCC). It has also raised urgent questions about the role of …